Awakn Life Sciences Corp. (AWKNF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 69.07 Thousand CAD | -92.25% |
| 2023 | 891.8 Thousand CAD | 422.15% |
| 2022 | -276.83 Thousand CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 69.07 Thousand CAD | -92.25% |
| 2024 Q4 | 17.05 Thousand CAD | -24.67% |
| 2024 Q3 | 22.63 Thousand CAD | 7.72% |
| 2024 Q2 | 21.01 Thousand CAD | -93.81% |
| 2024 Q1 | 339.57 Thousand CAD | 8.71% |
| 2023 FY | 891.8 Thousand CAD | 422.15% |
| 2023 Q3 | 279.81 Thousand CAD | 50.66% |
| 2023 Q4 | 312.35 Thousand CAD | 11.63% |
| 2023 Q2 | 185.72 Thousand CAD | 63.04% |
| 2023 Q1 | 113.91 Thousand CAD | 164.18% |
| 2022 Q3 | -99.34 Thousand CAD | -645.39% |
| 2022 Q2 | -13.32 Thousand CAD | -68.3% |
| 2022 Q1 | -7919.00 CAD | 0.0% |
| 2022 FY | -276.83 Thousand CAD | 0.0% |
| 2022 Q4 | -177.48 Thousand CAD | -78.66% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 99.539% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -2126.854% |
| SQZ Biotechnologies Company | 9.79 Million USD | 99.295% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 99.41% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 99.942% |
| Mesoblast Limited | -35.16 Million USD | 100.196% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 302.275% |
| Genus plc | 178.7 Million USD | 99.961% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 83.159% |
| Marizyme, Inc. | 457.7 Thousand USD | 84.908% |
| ContraFect Corporation | -154 Thousand USD | 144.855% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 727.973% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 238.154% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 10.01% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -5.095% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 117.826% |
| MultiCell Technologies, Inc. | 49.32 USD | -139958.8% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 99.828% |
| EV Biologics, Inc. | 48.9 Thousand USD | -41.262% |
| Q BioMed Inc. | -8988.00 USD | 868.547% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 99.756% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 547.854% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 99.969% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 1.319% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 155.595% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -11.01% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 1494.931% |
| Arch Therapeutics, Inc. | -2439.00 USD | 2932.185% |
| IMV Inc. | -962.29 Thousand USD | 107.178% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 50.835% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 170.837% |
| GB Sciences, Inc. | -624.00 USD | 11170.032% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 180.296% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.999% |
| Halberd Corporation | -208.00 USD | 33310.096% |
| Enzolytics Inc. | 30.7 Thousand USD | -124.948% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | 94.91% |
| SYBLEU INC | 11.69 Thousand USD | -490.604% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 85.682% |
| argenx SE | 1.1 Billion USD | 99.994% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 100.268% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 88.811% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.983% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 880.002% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 99.844% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 106.051% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 93.008% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 99.281% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 182.383% |
| BioStem Technologies, Inc. | 15.42 Million USD | 99.552% |
| ONE Bio Corp. | 20.12 Million USD | 99.657% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 683.667% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 243.138% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 60.876% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 60.876% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 113.426% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 110.962% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 338.197% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 84.651% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 121.62% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 98.501% |
| Bioxytran, Inc. | -8285.00 USD | 933.76% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 118.519% |
| Neutra Corp. | 14.33 Thousand USD | -381.877% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 184.24% |
| PureTech Health plc | -1.6 Million USD | 104.309% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 106.899% |
| IXICO plc | 3.27 Million USD | 97.888% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 109.953% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 103.857% |
| CSL Limited | 7.7 Billion USD | 99.999% |
| Cellectis S.A. | 18 Thousand USD | -283.761% |